UBS Upgrades Bruker BioSciences After Firm Announces Plan to Buy Bruker Optics

Apr 20, 2006

NEW YORK, April 20 (GenomeWeb News) - UBS today upgraded its assessment of Bruker BioSciences to "Buy" from "Neutral," two days after Bruker announced plans to purchase privately held Bruker Optics.

As GenomeWeb News reported on Tuesday, Bruker said it plans to pay $135 million for Bruker Optics, which makes molecular spectroscopy platforms, the companies said this week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Silencing for Preeclampsia

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

Settlement Expected in Duke Case

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

This Week in PNAS

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

Something Different

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.

Main menu